Lion Street Advisors, LLC Corcept Therapeutics Inc Transaction History

Lion Street Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$21.44 - $25.15 $287,296 - $337,010	13,400 New	13,400 $298,000
Q4 2022 Jan 19, 2023	BUY	$19.95 - $29.96 $234,412 - $352,030	11,750 New	11,750 $0
Q2 2022 Jul 19, 2022	BUY	$17.33 - $25.3 $203,627 - $297,275	11,750 New	11,750 $216,000
Q4 2021 Jan 20, 2022	SELL	$17.1 - $23.34 $200,925 - $274,245	-11,750 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $231,240 - $264,727	11,750 New	11,750 $234,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lion Street Advisors, LLC with notifications on news.